🇺🇸 FDA
Patent

US 10350256

Compositions for the treatment of dermatological conditions, disorders or diseases

granted A61KA61K31/07A61K31/23

Quick answer

US patent 10350256 (Compositions for the treatment of dermatological conditions, disorders or diseases) held by Veit Hoermann Gesellschaft Für Unternehmenskommunikation mbH expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Veit Hoermann Gesellschaft Für Unternehmenskommunikation mbH
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/07, A61K31/23, A61K31/355, A61K31/59